Abstract
We have designed a drug pathway identification system, which we called Drug Pathway Decipherer, to generate hypotheses on drug treatment responsive pathway. Decipherer takes in both pre- and post- treatment gene expression data, and evaluates known biological pathways against the data. We applied Decipherer to two gene expression datasets of human nasopharyngeal carcinoma treated with CYC202. Results show that the identified RAS-ERK pathway and PI3K-NFκB-IAP pathway are closely associated with treatment outcome. Decipherer is implemented in Java, and it is available together with supplementary material at http://www.comp.nus.edu.sg/~wongls/projects/drug-pathway
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Alvi, A., Austen, B., Weston, V., et al.: A novel CDK inhibitor, CYC202 (R-roscovitine), overcomes the defect in p53-independent apoptosis in B-CLL by down-regulation of genes involved in transcription regulation and survival. al 105, 4484–4491 (2005)
Doniger, S.W., Salomonis, N., Dahlquist, K.D., et al.: MAPPFinder: Using Gene Ontology and GenMAPP to create a global gene-expression profile from microarray data. Genome Biology 4(1), R7 (2003)
Draghici, S., Khatri, P., Tarca, A., et al.: A systems biology approach for pathway level analysis. Genome Research 17(10), 1537–1545 (2007)
Guo, Z., Li, Y., Gong, X., et al.: Edge-based scoring and searching method for identifying condition-responsive protein-protein interaction sub-network. Bioinformatics 23, 2121–2128 (2007)
Herrington, H.: Controlling the false discovery rate in multiple hypothesis testing, http://www.unt.edu/benchmarks/archives/2002/april02/rss.htm
Ideker, T., Ozier, O., Schwikowski, B., Siegel, A.F.: Discovering regulatory and signalling circuits in molecular interaction networks. Bioinformatics 18(suppl. 1), S233–S240 (2002)
Kanehisa, M., Goto, S., Kawashima, S., Nakaya, A.: The KEGG database at GenomeNet. Nucleic Acids Research 30(1), 42–46 (2002)
Lacrima, K., Valentini, A., Lambertini, C., et al.: In vitro activity of cyclin-dependent kinase inhibitor CYC202 (Seliciclib, R-roscovitine) in mantle cell lymphomas. Annals of Oncology 16, 1169–1176 (2005)
Lam, L., Pickeral, O., Peng, A., et al.: Genomic-scale measurement of mRNA turnover and the mechanisms of action of the anti-cancer drug flavopiridol. Genome Biology 2(10), research004 (2001)
McClue, S., Blake, D., Clarke, R., et al.: In vitro and in vivo antitumor properties of the cyclin dependent kinase inhibitor CYC202 (R-ROSCOVITINE). International Journal of Cancer 102, 463–468 (2002)
Meijer, L., Borgne, A., Mulner, O., et al.: Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinase cdc2, cdk2 and cdk5. European Journal of Biochemistry 243, 527–536 (1997)
Pathmanathan, R., Prasad, U., Sadler, R., et al.: Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma. The New England Journal of Medicine 333, 693–698 (1995)
Pui, C., Evans, W.: Acute lymphoblastic leukemia. New England Journal of Medicine 339, 605–615 (1998)
Raje, N., Kumar, S., Hideshima, T., et al.: Seliciclib (CYC202 or R-roscovitine), a small-molecule cyclin-dependent kinase inhibitor, mediates activity via down-regulation of MCL1 in multiple myeloma. Blood 106, 1042–1047 (2005)
Shi, W., Bastianutto, C., Li, A., et al.: Multiple dysregulated pathways in nasopharyngeal carcinoma revealed by gene expression profiling. International Journal of Cancer 119, 2467–2475 (2006)
Smith, P., Yue, E.: Inhibitors of Cyclin-dependent Kinases as Anti-tumor Agents. Taylor and Francis Group, Abington (2006)
Soh, D., Dong, D., Guo, Y., Wong, L.: Enabling more sophisticated gene expression analysis for understanding diseases and optimizing treatments. ACM SIGKDD Explorations 9, 3–14 (2007)
Subramanian, A., Tamayo, P., Mootha, V., et al.: Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proceedings of the National Academy of Science of the United States of America 102, 15545–15550 (2005)
Sultanem, K., Shu, H.K., Xia, P., et al.: Three-dimensional intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: the University of California, San Francisco experience. International journal of radiation oncology, biology, physics 48, 711–722 (2000)
Tan, W., Dong, D., Loh, M., et al.: Pathway determinants of 5-Fluorouracil activity. Poster. In: 20th EORTC-NCI-AACR symposium on Molecular targets and Cancer Therapeutics (2008)
Tsao, S., Tramoutanis, G., Dawson, C., et al.: The significance of LMP1 expression in nasopharyngeal carcinoma. Cancer Biology 12, 473–487 (2002)
Whittaker, S., Walton, M., Garrett, M., Workman, P.: The cyclin-dependent kinase inhibitor CYC202 (R-Roscovitine) inhibits retinoblastoma protein phosphorylation, causes loss of cyclin D1, and activates the mitogen-activated protein kinase pathway. Cancer Research 64, 262–272 (2004)
Yeoh, E., Ross, M., Shurtleff, S., et al.: Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling. Cancer Cell 1, 133–143 (2002)
Yu, M., Yuan, J.: Epidemiology of nasopharyngeal carcinoma. Seminars in Cancer Biology 12, 421–429 (2002)
Zeeberg, B.R., Feng, W., Wang, G., et al.: GoMiner: A resource for biological interpretation of genomic and proteomic data. Genome Biology 4(4), R28 (2003)
Zien, A., Kuffner, R., Zimmer, R., Lengauer, T.: Analysis of gene expression data with pathway scores. Proceedings of International Conference on Intelligent Systems for Molecular Biology 8, 407–417 (2000)
Pathway Ingenuity database, http://www.ingenuity.com/
WikiPathways, http://www.wikipathways.org/index.php/WikiPathways
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Dong, D., Cui, CY., Mow, B., Wong, L. (2009). Deciphering Drug Action and Escape Pathways: An Example on Nasopharyngeal Carcinoma. In: Rajasekaran, S. (eds) Bioinformatics and Computational Biology. BICoB 2009. Lecture Notes in Computer Science(), vol 5462. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-00727-9_20
Download citation
DOI: https://doi.org/10.1007/978-3-642-00727-9_20
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-00726-2
Online ISBN: 978-3-642-00727-9
eBook Packages: Computer ScienceComputer Science (R0)